Silver Book

Silver Book Fact

Mitral regurgitation patients who did not undergo surgery saw an increased use of medical therapies from 12% to 47% over 4.5 years.

Goel S, Bajaj N, Agaarwall B, Gupta S, et al. Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure. J Am Coll Cardiol. 2014; 63(2). http://www.onlinejacc.org/content/63/2/185

Reference

Title
Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure
Publication
J Am Coll Cardiol
Publication Date
2014
Authors
Goel S, Bajaj N, Agaarwall B, Gupta S, et al.
Volume & Issue
Volume 63, Issue 2
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Publications

Silver Book: Valve Disease Volume

 https://www.silverbook.org/wp-content/uploads/2018/02/SB-Vol-TN.jpg Thumbnail

Connected Facts

Aortic Stenosis

Fact image
Aortic stenosis often undertreated
Cost of Disease

Mitral Valve Disease

Fact image
Human Burden

Mitral Valve Disease

Fact image
Patients with severe MR who don’t have surgery have mortality rates of 20% after 1-year and 50% after 5-years
Human Burden

Aortic Stenosis

Fact image
Medicare patients with sSAS have an average lifespan of 1.8 years without repair or replacement
Human Burden

Related Facts

  • A recent study demonstrated that the cost of treating cardiovascular disease could rise by 64% to 84% by 2025.  
  • The number of inpatient discharges from short-stay hospitals with cardiovascular disease as the first-listed diagnosis increased from about 6,107,000 to 6,161,000 from 1996 to 2006.  
  • In 2008, cardiovascular disease accounted for 32.8% of all deaths in the U.S.–811,940, or 1 of every 3 deaths in the U.S.  
  • The prevalence of valve disease increases with age, from 0.7% in participants 18-44 to 13.3% in participants 75 years of age or older.  
  • 2005 Total Cardiovascular Disease Age-Adjusted Death Rates by State